Explore the full record of transactions filed by LEVIN ARTHUR A, Directeur Scientifique. Director active across 1 companies, notably Avidity Biosciences, Inc.. Cumulatively, 8 reports have been logged. Total volume traded: €599k. The latest transaction was filed on 18 November 2021 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Arthur A. Levin is the Chief Scientific Officer at Avidity Biosciences, Inc. He is responsible for leading the company's scientific and research initiatives. His expertise in the biotechnology field is crucial for developing new therapies.